DIVYA PERSAUD: Open Payments
NPI 1700477684 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,009 in 107 payments from 20 companies in 2025. Trend: 2023 $1,605 · 2024 $1,866 · 2025 $2,009
Food & beverage: $2,009
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $456 |
| Janssen Biotech, Inc. | 20 | $354 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $249 |
| PFIZER INC. | 9 | $206 |
| Madrigal Pharmaceuticals | 5 | $110 |
| Lilly USA, LLC | 5 | $98 |
| VIVUS LLC | 4 | $78 |
| Medtronic, Inc. | 1 | $70 |
| Celltrion USA Inc. | 3 | $69 |
| Gilead Sciences, Inc. | 3 | $62 |
Products named: TREMFYA, RINVOQ, VELSIPITY, ENTYVIO, REZDIFFRA, OMVOH, LINZESS, PANCREAZE.
Industry payments across FL — which companies pay providers there.
